Rgenix Scores Rare Multimillion Dollar Funding Round for New York Biotech Scene

Aug 31, 2015, 13:00 PM by Michael Croft

Xconomy | The startup company has raised $8 million in new capital to develop drugs based on a discovery program that searches for targets by measuring microRNA expression in cancer.

August 31, 2015 | The startup company has raised $8 million in new capital to develop drugs based on a discovery program that searches for targets by measuring microRNA expression in cancer. Xconomy